Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade

References

• Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0 Lyon: IARC Press; 2004.
   Google Scholar
• Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003;101(5 Pt 1):885–91.
   PubMedGoogle Scholar
• Elit L, Bondy SJ, Chen Z, Paszat L. A tale of two time periods: Ovarian cancer trends in Ontario. Curr Oncol 2007;14:57–60.
   PubMedGoogle Scholar
• Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue J, . Cancer incidence in five continents. Volume IX (IARC Scientific Publications No. 160). Lyon: IARC; 2007.
   Google Scholar
• Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, . Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004;91:935–41.
   PubMed Web of Science ®Google Scholar
• Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, . The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009;45:1006–16.
   PubMed Web of Science ®Google Scholar
• Capocaccia R, Gavin A, Hakulinen T, Lutz JM, Sant M. Survival of cancer patients in Europe, 1995–2002: The EUROCARE 4 Study. Eur J Cancer 2009;45:901–1094.
   PubMedGoogle Scholar
• Marth C, Hiebl S, Oberaigner W, Winter R, Leodolter S, Sevelda P. Influence of department volume on survival for ovarian cancer: Results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology. Int J Gynecol Cancer 2009;19:94–102.
   PubMedGoogle Scholar
• Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, . Ovarian cancer in younger vs older women: A population-based analysis. Br J Cancer 2006;95:1314–20.
   PubMed Web of Science ®Google Scholar
• Nagle CM, Bain CJ, Green AC, Webb PM. The influence of reproductive and hormonal factors on ovarian cancer survival. Int J Gynecol Cancer 2008;18:407–13.
   PubMedGoogle Scholar
• Jaaback K, Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2006:CD005340.
   PubMedGoogle Scholar
• De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, . The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009;45:909–30.
   PubMed Web of Science ®Google Scholar
• Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, . Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: Results of the EUROCARE-4 study. Lancet Oncol 2007;8:773–83.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemanni C, Santaquilani M, Knijn A, Marchesi F, Capocaccia F, . EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Percy C, Fritz A, Jack A, Shanmugarathan S, Sobin L, Parkin D, ., editors. International classification of diseases for oncology (ICD-O) 3rd ed. Geneva: WHO; 2000.
   Google Scholar
• Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, . Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784–96.
   PubMed Web of Science ®Google Scholar
• Cronin K, Mariotto A, Scoppa S, Green D, Clegg L. Differences between Brenner et al. and NCI methods for calculating period survival. Statistical Research and Applications Branch, National Cancer Institute. Technical Report #2003 -02-A [cited 2011 Nov 30]. Available from: http://surveillance.cancer.gov/reports/
   Google Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933–42.
   PubMed Web of Science ®Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Oehlert GW. A note on the delta method. Am Stat 1992;46:27–9.
   Web of Science ®Google Scholar
• Surveillance Research Program, SEER*Stat software 6.4.4 ed. Bethesda, MD: National Cancer Institute; 2008 [cited 2007 May 28]. Available from: www.seer.cancer.gov/seerstat.
   Google Scholar
• Berrino F, Capocaccia R, Coleman MP, Esteve J, Gatta G, Hakulinen T, . Survival of cancer patients in Europe: The EUROCARE-3 Study. Ann Oncol 2003;14(Suppl 5):9–155.
   PubMedGoogle Scholar
• Klint A, Tryggvadottir L, Bray F, Gislum M, Hakulinen T, Storm HH, . Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 2010;49:632–43.
   PubMed Web of Science ®Google Scholar
• Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, . Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011;377:127–38.
   PubMed Web of Science ®Google Scholar
• Estève J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: Elements for further discussion. Stat Med 1990;9:529–38.
   PubMed Web of Science ®Google Scholar
• Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Conditional survival in ovarian cancer: Results from the SEER dataset 1988–2001. Gynecol Oncol 2008;109:203–9.
   Google Scholar
• Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, . Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer 2010;20:945–52.
   PubMed Web of Science ®Google Scholar
• Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 2006;100:283–7.
   PubMedGoogle Scholar
• Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, . Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004;351:2489–97.
   PubMed Web of Science ®Google Scholar
• Akeson M, Zetterqvist BM, Holmberg E, Horvath G. Improved survival with clinical guidelines? Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998. Acta Obstet Gynecol Scand 2005;84:1113–8.
   PubMed Web of Science ®Google Scholar
• Du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 2005;15:183–91.
   PubMed Web of Science ®Google Scholar
• Kumpulainen S, Grenman S, Kyyronen P, Pukkala E, Sankila R. Evidence of benefit from centralised treatment of ovarian cancer: A nationwide population-based survival analysis in Finland. Int J Cancer 2002;102:541–4.
   PubMed Web of Science ®Google Scholar
• Oberaigner W, Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancers – a population-based study in Tyrol, Austria. Gynecol Oncol 2006;103:527–34.
   PubMedGoogle Scholar
• Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123:1897–901.
   PubMed Web of Science ®Google Scholar
• Rettenmaier MA, Lopez K, Abaid LN, Brown JV, 3rd, Micha JP, Goldstein BH. Borderline ovarian tumors and extended patient follow-up: An individual institution's experience. J Surg Oncol 2010;101:18–21.
   PubMed Web of Science ®Google Scholar
• Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, . Survival among women with borderline ovarian tumors and ovarian carcinoma: A population-based analysis. Cancer 2004;100:1045–52.
   PubMed Web of Science ®Google Scholar
• Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol 2002;87: 260–7.
   PubMed Web of Science ®Google Scholar
• Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, . Moderate progress for ovarian cancer in the last 20 years: Prolongation of survival, but no improvement in the cure rate. Eur J Cancer 2002;38:2435–45.
   PubMed Web of Science ®Google Scholar
• Brenner H, Stegmaier C, Ziegler H. Trends in survival of patients with ovarian cancer in Saarland, Germany, 1976–1995. J Cancer Res Clin Oncol 1999;125:109–13.
   PubMedGoogle Scholar
• Laurvick CL, Semmens JB, Leung YC, Holman CD. Ovarian cancer in Western Australia (1982–1998): Trends in surgical intervention and relative survival. Gynecol Oncol 2003;88:141–8.
   PubMedGoogle Scholar
• Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR. Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 2003;189:1120–7.
   PubMed Web of Science ®Google Scholar
• Fotopoulou C, Savvatis K, Steinhagen-Thiessen E, Bahra M, Lichtenegger W, Sehouli J. Primary radical surgery in elderly patients with epithelial ovarian cancer: Analysis of surgical outcome and long-term survival. Int J Gynecol Cancer 2010;20:34–40.
   PubMedGoogle Scholar
• Steer CB. Chemotherapy for ovarian cancer in the older adult. Curr Treat Options Oncol 2009;10:159–70.
   PubMedGoogle Scholar
• Janda M, Youlden DR, Baade PD, Jackson D, Obermair A. Elderly patients with stage III or IV ovarian cancer: Should they receive standard care? Int J Gynecol Cancer 2008;18: 896–907.
   PubMedGoogle Scholar
• Van Lent WAM, de Beer RD, van Harten WH. International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres. Bethesda, MD: National Center for Biotechnology Information; 2010 [cited 2010 Nov 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20807408.
   Google Scholar